We have previously found that IM vaccinated mice were protected against homologous HPAI challenge despite not producing IL-17 upon ex vivo re-stimulation of splenocytes [37], which suggests that IL-17 is dispensable in terms of effective vaccination against influenza. This evidence concerns the gene IL17A and influenza.